Acrobiosystems Co.,Ltd. (SHE:301080)

China · Delayed Price · Currency is CNY

41.41

+1.28 (3.19%)

At close: Jun 23, 2026

9.61% (1Y)

Market Cap	6.71B +10.7%
Revenue (ttm)	887.21M +29.4%
Net Income	171.25M +28.0%
EPS	1.04 +32.4%
Shares Out	167.18M
PE Ratio	38.62
Forward PE	23.20
Dividend	0.60 (1.49%)
Ex-Dividend Date	Jun 11, 2026

Volume	5,223,752
Open	39.80
Previous Close	40.13
Day's Range	39.73 - 41.99
52-Week Range	35.87 - 71.49
Beta	0.67
Analysts	Strong Buy
Price Target	72.71 (+75.59%)
Earnings Date	Aug 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2010

Employees 926

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301080

Full Company Profile

Financial Performance

In 2025, Acrobiosystems's revenue was 838.12 million, an increase of 29.94% compared to the previous year's 645.02 million. Earnings were 165.57 million, an increase of 33.70%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 301080 stock is "Strong Buy." The 12-month stock price target is ¥72.71, which is an increase of 75.59% from the latest price.

Price Target

¥72.71

(75.59% upside)

Analyst Consensus: Strong Buy

Stock Forecasts